WAUI
INSM icon

WELLINGTON-ALTUS USA INC.’s Insmed INSM Stock Holding History

WELLINGTON-ALTUS USA INC.’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.8K Hold
219
– – 0.03% 373
2026
Q1 		$23.4K Sell
219
-16
-7% -$2.46K 0.01% 489
2025
Q4 		$40.9K Buy
+235
New +$42.9K 0.03% 336

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

WELLINGTON-ALTUS USA INC.'s INSM Position: Q2 2026 in Review

WELLINGTON-ALTUS USA INC. held its Insmed (INSM) position steady in Q2 2026 at 219 shares worth $35.8K. The position accounts for 0.03% of the portfolio, ranked #373.

WELLINGTON-ALTUS USA INC. first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $40.9K in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • WELLINGTON-ALTUS USA INC. held 219 shares of Insmed worth $35.8K as of Q2 2026.
  • WELLINGTON-ALTUS USA INC. left its Insmed share count unchanged in Q2 2026.
  • Insmed made up 0.03% of WELLINGTON-ALTUS USA INC.'s portfolio in Q2 2026, its #373 holding.
  • WELLINGTON-ALTUS USA INC. first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • WELLINGTON-ALTUS USA INC.'s Insmed position peaked at $40.9K in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on WELLINGTON-ALTUS USA INC.'s 13F filing for Q2 2026, filed 17 Sep 2026.